cerevel.com - Nilai bisnis marang pendapatan CERE

Logo perusahaan publik Cerevel Therapeutics, Inc. (CERE)

Cerevel Therapeutics (CERE) focuses on developing cutting-edge medications to combat Alzheimer's disease and schizophrenia. The enterprise value-to-revenue multiple confirms market interest in these developments, with representing the latest level. Optimism is bolstered by long-term patent protection for target drugs and a successful merger with a pharmaceutical behemoth while maintaining scientific continuity.

Cerevel Corp (CERE): Rasio nilai perusahaan marang pendapatan saka 04.07.2022 nganti 20.11.2026

CERE (Cerevel Therapeutics, Inc.): rincian analitis lan laporan miturut indikator

- rega saham lan target rega konsensus:
- rincian nilai pasar emiten:
Pambiji fundamental perusahaan:CERE, Cerevel Therapeutics, Inc.
Produk seri cerevel.com

When selecting equity assets, reliability is assessed by comparing market capitalization adjusted for net debt to sales volume. This calculation determines the premium for future growth; however, for Cerevel Therapeutics (CERE), the risk of overvaluation is amplified by geopolitical barriers in component logistics and patent disputes, making a sharp change in the EV/Sales ratio a signal of a disconnect between quotes and actual revenue.

Pesaing langsung

BIIB (Biogen Inc.) - Rasio nilai perusahaan marang pendapatan|NBIX: Multiplikator EV/Sales|RGC (Regencell Bioscience Holdings Limited) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Axsome Therapeutics Inc|ACAD: Nilai bisnis marang pendapatan|Multiplikator EV/Sales XENE|Multiplikator EV/Sales vikingtherapeutics.com (VKTX)|Rasio nilai perusahaan marang pendapatan Supernus SUPN|Nilai bisnis marang pendapatan CPRX|denalitherapeutics.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Harmony Pharma HRMY|BHVN: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Amylyx Pharmaceuticals, Inc. (AMLX)|TRVI (Trevi Therapeutics Inc) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PRAX (Praxis Medicines)|Rasio nilai perusahaan marang pendapatan Anavex Life Sciences (AVXL)|Rasio nilai perusahaan marang pendapatan CBLL (CeriBell EEG)|Multiplikator EV/Sales PRTA (Prothena Corp)|alector.com (ALEC) - Multiplikator nilai perusahaan marang pendapatan|ANNX: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Omeros|NGNE: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan AC Immune|Nilai perusahaan marang pendapatan VYGR|Rasio nilai perusahaan marang pendapatan NMRA (neumoratx.com)|Nilai perusahaan marang pendapatan SCLX (Scilex Holding Company, Inc.)|Rasio nilai perusahaan marang pendapatan TVGN (Tevogen Bio)|Rasio nilai perusahaan marang pendapatan Alpha Cognition ACOG|CGTX - Nilai perusahaan marang pendapatan|IKT - Rasio nilai perusahaan marang pendapatan|SAVA: Rasio nilai perusahaan marang pendapatan|Assertio Therapeutics (ASRT) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Coya Therapeutics Inc (COYA)|Rasio nilai perusahaan marang pendapatan Vistagen|Rasio nilai perusahaan marang pendapatan OVID (ovidrx.com)|Rasio nilai perusahaan marang pendapatan Acumen Pharmaceuticals, Inc. (ABOS)|CRVO - Multiplikator nilai perusahaan marang pendapatan|Alterity Therapeutics Ltd. - Nilai perusahaan marang pendapatan|CLNN - Nilai perusahaan marang pendapatan|PEPG - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan jupiterneurosciences.com JUNS|Relmada Therapeutics (RLMD) - Rasio nilai perusahaan marang pendapatan|ANVS (Annovis Bio, Inc.) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan gracetx.com|Multiplikator EV/Sales Firefly Neuroscience, Inc.|Rasio nilai perusahaan marang pendapatan ANEW Medical (KLTO)|NRSN - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales RVPH (Reviva Pharmaceuticals Holdings Inc.)|Koefisien nilai perusahaan marang pendapatan MTVA (metaviatx.com)|NeurAxis Inc. - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan heliusmedical.com HSDT|PASG: Multiplikator EV/Sales|Neuphoria - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan NERV|ATHA: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales CYCN (cyclerion.com)|Rasio nilai perusahaan marang dodolan Protagenic|KTTA: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan CRGT (cortigent.com)|ATXI: Multiplikator EV/Sales|BCLI (BrainStorm Cell Therapeutics) - Rasio nilai perusahaan marang pendapatan|CARA (Cara Therapeutics Inc.) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan CHRO|Nilai perusahaan marang pendapatan ELYM (Eliem Therapeutics)|Rasio nilai perusahaan marang pendapatan ITCI (Intra-Cellular Therapies Inc.)|Multiplikator EV/Sales LBPH (Longboard Pharma)|Multiplikator EV/Sales Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Multiplikator EV/Sales|Nilai bisnis marang pendapatan NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan SNPX|Nilai perusahaan marang pendapatan TRVN|Rasio nilai perusahaan marang pendapatan VIGL|Multiplikator EV/Sales WENA